Your browser doesn't support javascript.
loading
A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly sensitive assay.
Hokama, Noboru; Shirakura, Takashi; Sunagawa, Sumito; Morishima, Satoko; Nakachi, Sawako; Nishi, Yukiko; Murayama, Yuko; Matsui, Chieko; Hase, Naoki; Tamura, Mizuho; Okamoto, Shiki; Shimabukuro, Michio; Nakamura, Katsunori; Masuzaki, Hiroaki.
Afiliación
  • Hokama N; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Shirakura T; Department of Hospital Pharmacy, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Sunagawa S; Pharmacology Research Department, Teijin Pharma Limited, Tokyo, Japan.
  • Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Nakachi S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Nishi Y; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Murayama Y; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Matsui C; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Hase N; Pharmacology Research Department, Teijin Pharma Limited, Tokyo, Japan.
  • Tamura M; Pharmacology Research Department, Teijin Pharma Limited, Tokyo, Japan.
  • Okamoto S; Pharmacology Research Department, Teijin Pharma Limited, Tokyo, Japan.
  • Shimabukuro M; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Nakamura K; Department of Diabetes, Endocrinology and Metabolism School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Masuzaki H; Department of Hospital Pharmacy, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
Hematol Oncol ; 37(4): 527-530, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31359444
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Xantina Oxidasa / Biomarcadores de Tumor / Neoplasias Hematológicas / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Xantina Oxidasa / Biomarcadores de Tumor / Neoplasias Hematológicas / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article